top of page
NJ.jpg

IN THE STATES

NEW JERSEY

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs and  economic impact data, clinical trial data, and vendor/supplier data from 16 biopharmaceutical companies regarding their business relationships with vendors and the total expenditures paid to vendors in New Jersey.

NJ.png

Economic
Output

$108.3B

Direct Jobs Supported by the Industry

63,415

Total Jobs Supported

340,751

State Total Vendor Relationships

5,566

State Total Vendor Spending

$7,920,347,489

Total Clinical
Trials

792

Dollar Amount Invested

$320.4M

Clinical Trial Participants

16,649

Total Economic Impact

$879.7M

bottom of page